- BNF:
- 8.2.1
- Status:
- Amber
- Decision Date:
- None
Comments
See shared care guideline for immunomodulating drugsAmber Drug Classifications
- 1: Requiring specialist assessment to enable patient selection and initiation of treatment
- 2: Requiring short or medium term (e.g. 3-6 months) specialist monitoring of efficacy or until the patient is stable
search again